TRISTEL PLC

Report Publication Announcement • Jan 15, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7844Z

Tristel PLC

15 January 2020

Tristel plc

("Tristel" or the "Company")

Investor results presentation

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, will announce the Company's interim results for the six months ended 31 December 2019 on Monday 24 February 2020.

Investor presentations

Paul Swinney, CEO, and Liz Dixon, CFO, will present the Company's results in two separate events open to all investors. The same presentation will be given at both events which are being held at different times to offer convenient options for those wishing to attend.

Two presentations will take place on Monday 24 February 2020 at the following times and location:

·     10.30 for a 10.45 start at The Brand Exchange, 3 Birchin Ln, London, EC3V 9BW

·     16.45 for a 17.00 start at The Brand Exchange, 3 Birchin Ln, London, EC3V 9BW

The presentations will be followed by refreshments. 

If you would like to register for either investor presentation, or require further information, please contact Lianne Cawthorne at Walbrook PR on 020 7933 8780 or email tristel@walbrookpr.com ensuring you detail in your email which presentation you would like to attend.

The results presentation will be made available on the Company's website www.tristel.com on the day of results.

For further information please contact:       

## Tristel plc	Tel: 01638 721 500
Paul Swinney, Chief Executive Officer
Liz Dixon, Finance Director
Walbrook PR Ltd	Tel: 020 7933 8780 or tristel@walbrookpr.com
Paul McManus	Mob: 07980 541 893
Lianne Cawthorne	Mob: 07584 391 303
finnCap	Tel: 020 7220 0500
Geoff Nash/ Giles Rolls (Corporate Finance)
Alice Lane (ECM)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NRABIMITMTTBBLM